Samantha C. Gouw

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study

Samantha C. Gouw, Johanna G. van der Bom, H. Marijke van den Berg · Blood · 2007 · 487 citations

Medicine, Hematology, Pharmacotherapy +14

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung et al. · New England Journal of Medicine · 2013 · 436 citations · Full text

Medicine, Hematology, Pediatrics +16

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

Samantha C. Gouw, H. Marijke van den Berg, Kathelijn Fischer et al. · Blood · 2013 · 323 citations

Medicine, Hematology, Pediatrics +17

Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study

Samantha C. Gouw, Johanna G. van der Bom, Günter Auerswald et al. · Blood · 2007 · 236 citations

Medicine, Hematology, Hemostasis +13

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A

Samantha C. Gouw, H. Marijke van den Berg, Saskia le Cessie et al. · Journal of Thrombosis and Haemostasis · 2007 · 142 citations · Full text

Medicine, Hematology, Pharmacotherapy +14